Directors' Dealings
Disclosure of securities transaction
The members of the Management Board and Supervisory Board of the Fresenius Medical Care Management AG are obligated to notify the German Federal Financial Supervisory Authority and the corporation about the purchase or sales of Fresenius Medical Care AG & Co. KGaA shares under Art. 15a of the Securities Trading Act (Wertpapierhandelsgesetz). The disclosure of such securities transactions is also part of the German Governance Code (Paragraph 6.6). In addition to the direct purchase or sale of Fresenius Medical Care AG & Co. KGaA shares, other securities transactions relating to Fresenius Medical Care AG & Co. KGaA shares (e.g. purchase or sale of option certificates for Fresenius Medical Care AG & Co. KGaA stock) must also be disclosed. Spouses, registered life partners or first grade relatives are also subject to disclosure rules for security dealing.
The corporation is obliged to publish all notifications received from its board members on its website.
Detailed information on the notification obligations can be drawn from the respective section of the law (German Securities Trade Act, section 15a).
Awards 2008
- LACP: Platinum Awards for the Annual Report 2007
- Institutional Investor: Best European Investor Relations in the Healthcare Sector in 2008
- Capital: Investor Relations Award 2008 for the best IR in the DAX
- Thomson Extel Surveys: IR Excellence Award 2008
- IR Global Rankings: Best IR Team and TOP 1 Online Annual Report in the Industry
Awards 2007
- Thomson Extel Surveys: Best IR Work in Europe 2007
- Institutional Investor: Best European Investor Relations in the Healthcare Sector in 2007
- Capital: Investor Relations Award 2007 for the best IR in the DAX
- Manager Magazin: Best Annual Report 2007 in the DAX
- LACP: Platinum Award for the Annual Report 2006




top